Sensitive and rapid liquid chromatography/tandem mass spectrometric assay for the quantification of piperaquine in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 859, Issue 1, 2007, Pages 24-29

  Singhal, Puran ^a   Gaur, Ashwani ^a   Gautam, Anirudh ^a   Varshney, Brijesh ^a   Paliwal, Jyoti ^a   Batra, Vijay ^a  

^a RANBAXY RESEARCH LABORATORIES   (India)

Author keywords

Antimalarial: Piperaquine; Human plasma; Liquid chromatography tandem mass spectrometry

Indexed keywords

DRUG PRODUCTS; DRUG THERAPY; FORMIC ACID; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEINS;

CHLOROQUINOLINE; PHARMACOKINETIC PARAMETERS; PIPERAQUINE; TANDEM MASS SPECTROMETRY;

PLASMA (HUMAN);

AMMONIA; AMMONIUM ACETATE; FORMIC ACID; METHANOL; PIPERAQUINE;

ARTICLE; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; STANDARD; TANDEM MASS SPECTROMETRY;

ANTIMALARIALS; CHROMATOGRAPHY, LIQUID; HUMANS; QUINOLINES; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 35548987568     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.09.021     Document Type: Article

References (15)

1. Tran T.H., Dolecek C., Pham P.M., Nguyen T.D., Nguyen T.T., Le H.T., Dong T.H., Tran T.T., Stepniewska K., White N.J., and Farrar J. Lancet 363 (2004) 18
2. Karunajeewa H., Lim C., Hung T.Y., Ilett K.F., Denis M.B., Socheat D., and Davis T.M. Br. J. Clin. Pharmacol. 57 (2004) 93
3. Hung T.Y., Davis T.M., Ilett K.F., Karunajeewa H., Hewitt S., Denis M.B., Lim C., and Socheat D. Br. J. Clin. Pharmacol. 57 (2004) 253
4. Giao P.T., Vries P.J.D., Hung Q.L., Binh T.Q., Nam N.V., and Kager P.A. Trop. Int. Health 9 (2004) 209
5. Roshammar D., Hai T.N., Friberg S.H., Van N.H., and Ashton M. Eur. J. Clin. Pharmacol. 62 (2006) 335
6. Lindegardh N., Ashton M., and Bergqvist Y. J. Chromatogr. Sci. 41 (2003) 41
7. Hung T.Y., Davis T.M., and Ilett K.F. J. Chromatogr. B 791 (2003) 93
8. Lindegardh N., Ashton M., and Bergqvist Y. Ther. Drug Monit. 25 (2003) 544
9. Malm M., Lindegardh N., and Bergqvist Y. J. Chromatogr. B 809 (2004) 43
10. Lindegardh N., White N.J., and Day N.P. J. Pharm. Biomed. Anal. 39 (2005) 601
11. Tarning J., Singtoroj T., Annerberg A., Ashton M., Bergqvist Y., White N.J., Day N.P., and Lindegardh N. J. Pharm. Biomed. Anal. 41 (2006) 213
12. Jessome L.L., and Volmer D.A. LCGC North America 24 (2006) 498
13. Ramakrishna N.V., Vishwottam K.N., Puran S., Manoj S., Santosh M., and Koteshwara M. J. Mass Spectrom. 39 (2004) 824
14. Tarning J., Lindegardh N., Annerberg A., Singtoroj T., Day N.P., Ashton M., and White N.J. Antimicrob. Agents Chemother. 49 (2005) 5127
15. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD, 2001.